skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version:24.07e (Release date:2024-07-29)
SearchBox Top
SearchBox Bottom
Eluvixtamab (Code C123332)

Terms & Properties

Preferred Name:  Eluvixtamab

Definition:  A proprietary recombinant bispecific T-cell engager (BiTE) antibody composed of two single-chain variable fragments (scFv), one directed against the tumor-associated antigen (TAA) CD33 fused to one that is directed against the CD3 antigen found on T-lymphocytes, with potential immunostimulating and antineoplastic activities. Upon administration of eluvixtamab, this bispecific antibody binds to both the CD3 antigen on cytotoxic T-lymphocytes (CTLs) and the CD33 antigen found on CD33-expressing tumor cells. This activates and redirects CTLs to CD33-expressing tumor cells, which results in the CTL-mediated cell death of CD33-expressing tumor cells. CD33, a myeloid differentiation antigen, is expressed on normal non-pluripotent hematopoietic stem cells and overexpressed on neoplastic cells in patients with acute myeloid leukemia.

Display Name:  Eluvixtamab

Label:  Eluvixtamab

NCI Thesaurus Code:  C123332 (Search for linked caDSR metadata)   (search value sets)

NCI Metathesaurus Link:  C3851031  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
AMG 330
AMG-330
AMG330
Anti-CD33/CD3 BiTE Antibody AMG 330
Bispecific T-cell Engager Antibody AMG 330
BiTE Antibody AMG 330
CD33/CD3-directed Bispecific T-cell Engager Antibody AMG 330
Eluvixtamab
ELUVIXTAMAB

External Source Codes: 
CAS Registry Number 1679391-73-1 (see NLM ChemIDplus info)
NCI Drug Dictionary ID 775135 (see NCI Drug Dictionary info)
FDA UNII Code 6Z4B5PJ4OP
PDQ Closed Trial Search ID 775135
PDQ Open Trial Search ID 775135
UMLS CUI C3851031

Other Properties:
     Name Value (qualifiers indented underneath)
code C123332
Contributing_Source CTRP
Contributing_Source FDA
Contributing_Source GDC
Contributing_Source HemOnc
Maps_To Anti-CD33/CD3 BiTE Antibody AMG 330
      Target_Terminology: GDC
      Relationship_to_Target: Has Synonym
      Target_Term_Type: PT
      Target_Code: therapeutic_agents
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL:https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C123332

Mainbox Bottom